Anoro Ellipta
umeclidinium bromide and vilanterol trifenatate
- Strength
- 62.5 ug/1, 25 ug/1
- Form
- Powder
- Class
- Anticholinergic; beta2-Adrenergic Agoni…
GlaxoSmithKline LLC
Not stocked by us — reference only
umeclidinium bromide and vilanterol trifenatate
Listed by Prasco Laboratories
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Powder |
|---|---|
| Route | Respiratory (inhalation) |
| Drug class | Anticholinergic; beta2-Adrenergic Agonist |
| Approval route | Authorised generic |
| NDC code | 66993-134 |
| FDA application | NDA203975 |
| RxNorm concept | 1487527 |
| Package sizes listed | 1 |
| Marketed since | April 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
umeclidinium bromide and vilanterol trifenatate
GlaxoSmithKline LLC
Not stocked by us — reference only
umeclidinium
GlaxoSmithKline LLC
Not stocked by us — reference only
umeclidinium
Prasco Laboratories
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.